Emerg Infect Dis. 2006 Jan;12(1):66-72.

Vaccines for pandemic influenza.

Source

National Institutes of Health, Bethesda, Maryland 20892, USA.

Abstract

Recent outbreaks of highly pathogenic avian influenza in Asia and associated human infections have led to a heightened level of awareness and preparation for a possible influenza pandemic. Vaccination is the best option by which spread of a pandemic virus could be prevented and severity of disease reduced. Production of live attenuated and inactivated vaccine seed viruses against avian influenza viruses, which have the potential to cause pandemics, and their testing in preclinical studies and clinical trials will establish the principles and ensure manufacturing experience that will be critical in the event of the emergence of such a virus into the human population. Studies of such vaccines will also add to our understanding of the biology of avian influenza viruses and their behavior in mammalian hosts.

PMID:: 16494720; [PubMed - indexed for MEDLINE]
PMCID:: PMC3291408

Free PMC Article

Images from this publication.See all images (1) Free text

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

Influenza Vaccines

LinkOut - more resources

Full Text Sources

Medical

Supplemental Content

Save items

Related citations in PubMed

Development of a new candidate H5N1 avian influenza virus for pre-pandemic vaccine production. [Influenza Other Respi Viruses....]
Development of a new candidate H5N1 avian influenza virus for pre-pandemic vaccine production.
Dong J, Matsuoka Y, Maines TR, Swayne DE, O'Neill E, Davis CT, Van-Hoven N, Balish A, Yu HJ, Katz JM, et al. Influenza Other Respi Viruses. 2009 Nov; 3(6):287-95.
Antigenic and genetic characteristics of H5N1 viruses and candidate H5N1 vaccine viruses developed for potential use as pre-pandemic vaccines. [Wkly Epidemiol Rec. 2006]
Antigenic and genetic characteristics of H5N1 viruses and candidate H5N1 vaccine viruses developed for potential use as pre-pandemic vaccines.
. Wkly Epidemiol Rec. 2006 Aug 25; 81(34/35):328-30.
Review Designing vaccines for pandemic influenza. [Curr Top Microbiol Immunol. 2009]
Review Designing vaccines for pandemic influenza.
Horimoto T, Kawaoka Y. Curr Top Microbiol Immunol. 2009; 333:165-76.
Review Development of a mucosal vaccine for influenza viruses: preparation for a potential influenza pandemic. [Expert Rev Vaccines. 2007]
Review Development of a mucosal vaccine for influenza viruses: preparation for a potential influenza pandemic.
Hasegawa H, Ichinohe T, Tamura S, Kurata T. Expert Rev Vaccines. 2007 Apr; 6(2):193-201.
Review Strategies for developing vaccines against H5N1 influenza A viruses. [Trends Mol Med. 2006]
Review Strategies for developing vaccines against H5N1 influenza A viruses.
Horimoto T, Kawaoka Y. Trends Mol Med. 2006 Nov; 12(11):506-14. Epub 2006 Sep 29.

See reviews... See all...

Cited by 20 PubMed Central articles

Pandemic influenza vaccines - the challenges. [Viruses. 2009]
Pandemic influenza vaccines - the challenges.
Haaheim LR, Madhun AS, Cox R. Viruses. 2009 Dec; 1(3):1089-109. Epub 2009 Dec 3.
An open label Phase I trial of a live attenuated H6N1 influenza virus vaccine in healthy adults. [Vaccine. 2011]
An open label Phase I trial of a live attenuated H6N1 influenza virus vaccine in healthy adults.
Talaat KR, Karron RA, Luke CJ, Thumar B, McMahon BA, Chen GL, Lamirande EW, Jin H, Coelingh KL, Kemble G, et al. Vaccine. 2011 Apr 12; 29(17):3144-8. Epub 2011 Mar 4.
A live attenuated H7N7 candidate vaccine virus induces neutralizing antibody that confers protection from challenge in mice, ferrets, and monkeys. [J Virol. 2010]
A live attenuated H7N7 candidate vaccine virus induces neutralizing antibody that confers protection from challenge in mice, ferrets, and monkeys.
Min JY, Vogel L, Matsuoka Y, Lu B, Swayne D, Jin H, Kemble G, Subbarao K. J Virol. 2010 Nov; 84(22):11950-60. Epub 2010 Sep 1.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Vaccines for pandemic influenza.
Vaccines for pandemic influenza.
Emerg Infect Dis. 2006 Jan ;12(1):66-72.

PubMed
H5N1 outbreaks and enzootic influenza.
H5N1 outbreaks and enzootic influenza.
Emerg Infect Dis. 2006 Jan ;12(1):3-8.

PubMed
Infections during induction therapy of childhood acute lymphoblastic leukemia--n...
Infections during induction therapy of childhood acute lymphoblastic leukemia--no association to mannose-binding lectin deficiency.
Eur J Haematol. 2006 Jun ;76(6):481-7. Epub 2006 Feb 23 .

PubMed
Complementary and alternative provider use by insured patients with diabetes in ...
Complementary and alternative provider use by insured patients with diabetes in Washington State.
J Altern Complement Med. 2006 Jan-Feb ;12(1):71-7.

PubMed
Abnormally high plasma levels of vitamin B6 in children with autism not taking s...
Abnormally high plasma levels of vitamin B6 in children with autism not taking supplements compared to controls not taking supplements.
J Altern Complement Med. 2006 Jan-Feb ;12(1):59-63.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: